Company Puma Biotechnology Inc Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Care Products
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/18/05 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/13/01 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 01/20/01 |
Douglas Hunt
LAW | General Counsel | 59 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/18/23 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/12/27 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
Director/Board Member | 63 | 29/22/29 | |
Director/Board Member | 60 | 11/15/11 | |
Troy Wilson
BRD | Director/Board Member | 55 | 18/13/18 |
Allison Dorval
BRD | Director/Board Member | 48 | 15/21/15 |
Brian Stuglik
BRD | Director/Board Member | 64 | 05/20/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,238,850 | 40,808,140 ( 84.60 %) | 0 | 84.60 % |
Company contact information
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |